Jazz Pharmaceuticals PLC Net Asset Quality Index
Jazz Pharmaceuticals PLC net asset quality index. Jazz Pharmaceuticals PLC (JAZZ) has a Net Asset Quality Index of 38.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $11.86 Billion minus total liabilities of $7.33 Billion yields net assets of $4.53 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check JAZZ cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Jazz Pharmaceuticals PLC (2005–2025)
Net asset quality index of Jazz Pharmaceuticals PLC from 2005 to 2025. This chart shows how Jazz Pharmaceuticals PLC's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of March 2026, the index stands at 38.2%, representing net assets of $4.53 Billion against total assets of $11.86 Billion USD. See JAZZ book value for net asset value and shareholders' equity analysis.
Jazz Pharmaceuticals PLC Net Asset Quality Index by Year (2005–2025)
Jazz Pharmaceuticals PLC net asset quality index by year from 2005 to 2025. The table below presents the year-by-year Net Asset Quality Index for Jazz Pharmaceuticals PLC from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Jazz Pharmaceuticals PLC.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 37.0% | $4.32 Billion | $11.66 Billion | $7.34 Billion | ▲ +3.0 pp |
| 2024 | 34.1% | $4.09 Billion | $12.01 Billion | $7.92 Billion | ▲ +1.3 pp |
| 2023 | 32.8% | $3.74 Billion | $11.39 Billion | $7.66 Billion | ▲ +4.3 pp |
| 2022 | 28.5% | $3.09 Billion | $10.84 Billion | $7.75 Billion | ▼ -3.8 pp |
| 2021 | 32.2% | $3.97 Billion | $12.30 Billion | $8.33 Billion | ▼ -23.8 pp |
| 2020 | 56.0% | $3.66 Billion | $6.54 Billion | $2.88 Billion | ▼ -0.2 pp |
| 2019 | 56.2% | $3.11 Billion | $5.54 Billion | $2.43 Billion | ▲ +3.2 pp |
| 2018 | 53.0% | $2.76 Billion | $5.20 Billion | $2.45 Billion | ▲ +0.0 pp |
| 2017 | 53.0% | $2.71 Billion | $5.12 Billion | $2.41 Billion | ▲ +13.8 pp |
| 2016 | 39.1% | $1.88 Billion | $4.80 Billion | $2.92 Billion | ▼ -8.5 pp |
| 2015 | 47.6% | $1.60 Billion | $3.36 Billion | $1.76 Billion | ▲ +6.5 pp |
| 2014 | 41.1% | $1.37 Billion | $3.34 Billion | $1.97 Billion | ▼ -16.8 pp |
| 2013 | 57.9% | $1.30 Billion | $2.24 Billion | $942.69 Million | ▲ +0.9 pp |
| 2012 | 57.0% | $1.12 Billion | $1.97 Billion | $845.20 Million | ▼ -19.0 pp |
| 2011 | 76.0% | $192.79 Million | $253.57 Million | $60.78 Million | ▲ +53.5 pp |
| 2010 | 22.5% | $30.55 Million | $135.73 Million | $105.18 Million | ▲ +90.3 pp |
| 2009 | -67.8% | $-72.83 Million | $107.40 Million | $180.23 Million | ▲ +11.2 pp |
| 2008 | -79.0% | $-92.88 Million | $117.50 Million | $210.38 Million | ▼ -105.5 pp |
| 2007 | 26.5% | $54.99 Million | $207.55 Million | $152.56 Million | ▲ +108.7 pp |
| 2006 | -82.2% | $-176.30 Million | $214.57 Million | $390.87 Million | ▼ -10.4 pp |
| 2005 | -71.8% | $-118.25 Million | $164.78 Million | $283.03 Million | — |